Clinical benefit of cancer drugs approved in Switzerland 2010-2019.

PLoS One · 2022 · PMC9187080 · PMID 35687539

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an encouraging trendno p-value reported

However, there is an encouraging trend that more recent registration trials evaluate HRQoL more often as a secondary outcome than this was done in older registration trials.

also in 355 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.